Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Feb 18;10(2):e035672.
doi: 10.1136/bmjopen-2019-035672.

Efficacy and Safety of a Supplement Combination for Hand Osteoarthritis Pain: Protocol for an Internet-Based Randomised Placebo-Controlled Trial (The RADIANT Study)

Affiliations
Free PMC article

Efficacy and Safety of a Supplement Combination for Hand Osteoarthritis Pain: Protocol for an Internet-Based Randomised Placebo-Controlled Trial (The RADIANT Study)

Xiaoqian Liu et al. BMJ Open. .
Free PMC article

Abstract

Introduction: Hand osteoarthritis (HOA) is a highly prevalent disabling joint disease. The current management regimens are limited. Potentially as a consequence, many people turn to complementary and alternative medicines for symptomatic relief. A combination of two or more supplements is common in clinical practice; however, evidence for the efficacy of this approach is lacking. The aim of this study is to investigate the efficacy of a supplement combination for treating symptomatic HOA in comparison to placebo.

Methods and analysis: The RADIANT study is an internet-based, parallel, superiority, double-blind, placebo-controlled, randomised, two-arm clinical trial. A participatory design is used to facilitate the study procedures. One hundred and six participants aged over 40 years with painful HOA and structural change on X-ray (Kellgren and Lawrence grade (KLG) ≥2) will be recruited from the community and randomly allocated to receive either a supplement combination composed of: (1) combined supplement containing Boswellia serrata extract, pine bark extract and methylsulfonylmethane and (2) curcumin or placebo for 12 weeks. The primary outcome will be 12-week change in hand pain on a visual analogue scale (VAS). Main secondary outcomes include adverse events, change in hand function, patient global assessment of disease activity and quality of life. A range of additional measures will be recorded, and an individual patient placebo response will be performed. The primary analysis will be conducted using an intention-to-treat approach. Adverse events will be monitored weekly throughout the study.

Ethics and dissemination: This protocol has been approved by the University of Sydney Human Research Ethics Committee (HREC No. 2018/766). Dissemination will occur through conferences, social media, scientific publications and PhD thesis.

Trial registration number: Australian New Zealand Clinical Trials Registry (ACTRN12619000835145); Pre-results.

Keywords: clinical trials; hand & wrist; musculoskeletal disorders; rheumatology.

Conflict of interest statement

Competing interests: DJH is supported by an NHMRC Practitioner Fellowship and provides consulting advice for Merck Serono, TLC Bio, Tissuegene and Pfizer. Unity Health provides the Sydney Pharmacy School for a researcher’s salary for a project led by AM that maintains a database of herb–drug interaction. AM has served as pharmacokinetic consult to BOD Australia on a study investigating cannabidiol bioavailability (ACTRN12618000391279).

Figures

Figure 1
Figure 1
Flow diagram of the study protocol. IBJR, Institute of Bone and Joint Research.

Similar articles

See all similar articles

References

    1. GBD 2016 Disease and Injury Incidence and Prevalence Collaborators Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the global burden of disease study 2016. Lancet 2017;390:1211–59. 10.1016/S0140-6736(17)32154-2 - DOI - PMC - PubMed
    1. Cross M, Smith E, Hoy D, et al. The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis 2014;73:1323–30. 10.1136/annrheumdis-2013-204763 - DOI - PubMed
    1. Marshall M, Peat G, Nicholls E, et al. Subsets of symptomatic hand osteoarthritis in community-dwelling older adults in the United Kingdom: prevalence, inter-relationships, risk factor profiles and clinical characteristics at baseline and 3-years. Osteoarthritis Cartilage 2013;21:1674–84. 10.1016/j.joca.2013.08.004 - DOI - PMC - PubMed
    1. Haugen IK, Englund M, Aliabadi P, et al. Prevalence, incidence and progression of hand osteoarthritis in the general population: the Framingham osteoarthritis study. Ann Rheum Dis 2011;70:1581–6. 10.1136/ard.2011.150078 - DOI - PMC - PubMed
    1. Kodama R, Muraki S, Oka H, et al. Prevalence of hand osteoarthritis and its relationship to hand pain and grip strength in Japan: the third survey of the road study. Mod Rheumatol 2016;26:767–73. 10.3109/14397595.2015.1130673 - DOI - PubMed

LinkOut - more resources

Feedback